Agenus ($AGEN) Insider Trading & Smart Money Activity

Agenus Inc. · Biotechnology · Latest filing Jun 26, 2026

Agenus Inc. ($AGEN) has 2 insider trades on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

AGEN insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AGEN insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 26, 2026	Insider	Garo ArmenChairman, Chief Executive Officer and Principal Financial Officer	Buy (Grant or award)	5.36K sh	$16.25K		+12.5%	+102.3%			Read
Jun 12, 2026	Insider	Garo ArmenChairman, Chief Executive Officer and Principal Financial Officer	Buy (Grant or award)	4.92K sh	$16.25K		-7.9%	+85.5%			Read

1W / 1M / 6M = how AGEN moved from the trade or filing date.

Insider trading in AGEN: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Garo Armen	Chairman, Chief Executive Officer and Principal Financial Officer	2	—		Jun 26, 2026

Frequently asked questions

What is the latest insider trade in AGEN?

Garo Armen, Chairman, Chief Executive Officer and Principal Financial Officer filed a buy (grant or award) of 5.36K sh worth $16.25K on Jun 26, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text